Compare Bio Protocol (BIO) vs Gains Network (GNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Gains Network — how do they compare? Bio Protocol trades at Rp438.76 (market cap Rp997,43M, Rp162,4M 24h volume), while Gains Network trades at Rp9,371 (market cap Rp219,45M, Rp6,02M 24h volume). The key difference: Bio Protocol is far larger — about 4.5× Gains Network's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Gains Network's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Gains Network for 47 Days on average.
| BIO | GNS | |
|---|---|---|
Market Cap | Rp997,43M | Rp219,45M |
Volume (24h) | Rp162,4M | Rp6,02M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 23,4M GNS |
Typical Hold Time | 18 Days | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Gains Network (GNS) is trading at Rp9,382 with a market cap of Rp219.2 million, showing a bullish technical signal despite bearish moving averages. The token is near key support at Rp9,260, with RSI_6 indicating overbought conditions at 86.88. Recent on-chain data shows an average hold time of 47 days, suggesting moderate holder commitment. No major protocol upgrades or ecosystem developments were reported recently, keeping fundamental activity subdued.
Overall outlook is cautiously optimistic due to bullish momentum, but risks include high volatility from low liquidity and regulatory uncertainties in crypto markets. Key opportunities lie in potential breakout above resistance at Rp9,533, while major risks involve price sensitivity to low trading volumes and broader market sentiment shifts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Gains Network
Gains Network is developing gTrade, a liquidity-efficient, powerful, and user-friendly decentralized leveraged trading platform. The protocol revolves around the ecosystem's ERC20 utility token (GNS) and ERC721 utility token (NFTs). It is a DAO governed by the $GNS token with the goal to create DeFi products that bring revenue that can be distributed in a $GNS staking pool.
Read more on GNS →
